Texas sues J&J's Janssen Pharma

The state of Texas is suing Johnson & Johnson's Janssen Pharmaceuticals, alleging that the drug company used Texas mental health officials as "pitchmen" and carried out other unseemly tactics to get its antipsychotic medication, Risperdal, on Texas's Medicaid preferred provider drug list. In addition, the state is accusing New Jersey-based Janssen of supplying phony advocacy groups and making other attempts to influence positioning of the medication, essentially defrauding the state over the last 10 years. Report

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.